Cover Image

Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database

Background: Pancreatitis is characterized by inflammation of the pancreas and significantly affects quality of life. Less than 5% of pancreatitis cases are drug-induced, but recent evidence suggests a substantial risk associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The aim of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Khalidah A. Alenzi (Author), Deemah Alsuhaibani (Author), Bader Batarfi (Author), Thamir M. Alshammari (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medication Errors in Psychiatric Hospitals: A Nationwide Real-World Evidence Study in Saudi Arabia
by: Khalidah A. Alenzi, et al.
Published: (2024)

Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example
by: Thamir M. Alshammari, et al.
Published: (2020)

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database
by: Ali F. Altebainawi, et al.
Published: (2023)

Coronavirus disease 2019 in Saudi Arabia: A nationwide real-world characterization study
by: Khalidah A. Alenzi, et al.
Published: (2022)

Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health
by: Thamir M. Alshammari, et al.
Published: (2023)

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System
by: Deemah S. Alsuhaibani, et al.
Published: (2023)

Are countries' precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide
by: Thamir M. Alshammari, et al.
Published: (2021)

Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics' impact
by: Ohoud A. Almadani, et al.
Published: (2022)

Patient's medicinal knowledge in Saudi Arabia:
by: Thamir M. Alshammari
Published: (2016)

Direct healthcare professional communications: A quantitative assessment study
by: Hajar Alsaleh, et al.
Published: (2021)

Pharmacists' roles in emergency and disasters: COVID-19 as an example
by: Wejdan Aburas, et al.
Published: (2020)

Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015
by: Alshammari TM, et al.
Published: (2018)

Pharmacovigilance system in Saudi Arabia
by: Thamir M. Alshammari, et al.
Published: (2017)

Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study
by: Thamir M. AlShammari, et al.
Published: (2018)

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
by: Fan Zou, et al.
Published: (2023)

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
by: Liyuan Liu
Published: (2024)

Health outcomes and policy in pharmay curricula among Arab countries: An evaluation of 191 academic institutions
by: Eman A. Alghamdi, et al.
Published: (2021)

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
by: Omar M. Albalawi, et al.
Published: (2022)

Health economic burden of COVID-19 in Saudi Arabia
by: Khalidah A. Alenzi, et al.
Published: (2022)

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
by: Dan Zhao, et al.
Published: (2024)

Energy drinks and population health: consumption pattern and adverse effects among Saudi population
by: Gehad M. Subaiea, et al.
Published: (2019)

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
by: Jianxing Zhou, et al.
Published: (2022)

Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis B disease and vaccination in Saudi Arabia
by: Thamir M. Alshammari, et al.
Published: (2019)

Comparison of the safety information on drug labels in three developed countries: The USA, UK and Canada
by: Thamir M. Alshammari, et al.
Published: (2017)

Real-world pharmacovigilance analysis of galsulfase: a study based on the FDA adverse event reporting system (FAERS) database
by: Shangze Li, et al.
Published: (2024)

Are drug safety measures harmonized? A real-world evidence from three regulatory authorities
by: Sadeem Alelayan, et al.
Published: (2024)

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022
by: Marwan A. Alrasheed, et al.
Published: (2024)

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
by: Zhiwei Cui, et al.
Published: (2023)

Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)
by: Lin Zhang, et al.
Published: (2023)

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database
by: Junwei Wang, et al.
Published: (2024)

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab
by: Yue He, et al.
Published: (2024)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
by: Xusheng Zhang, et al.
Published: (2024)

Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
by: Risako Hirai, et al.
Published: (2023)

Healthcare professionals' knowledge, attitude and acceptance of influenza vaccination in Saudi Arabia: a multicenter cross-sectional study
by: Thamir M. Alshammari, et al.
Published: (2019)

Pharmacy Malpractice: The rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia
by: Thamir M. Alshammari, et al.
Published: (2017)

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database
by: Fei W, et al.
Published: (2023)

A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database
by: Huanying Xu, et al.
Published: (2024)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)
by: Huafei Tang, et al.
Published: (2024)